HemaSphere (Aug 2023)
P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES
- Laura Martinez-Verbo,
- Lorea Villanueva,
- Pere Llinàs-Arias,
- Carlos Antonio García-Prieto,
- David Piñeyro,
- Aina Oliver-Caldes,
- Almudena García-Ortiz,
- Antonio Valeri,
- Carlos Fernández De Larrea,
- Joaquin Martínez-López,
- Gerardo Ferrer,
- Manel Esteller
Affiliations
- Laura Martinez-Verbo
- 1 Josep Carreras Leukaemia Research Institute, Cancer Epigenetics, Badalona, Spain
- Lorea Villanueva
- 1 Josep Carreras Leukaemia Research Institute, Cancer Epigenetics, Badalona, Spain
- Pere Llinàs-Arias
- 1 Josep Carreras Leukaemia Research Institute, Cancer Epigenetics, Badalona, Spain
- Carlos Antonio García-Prieto
- 1 Josep Carreras Leukaemia Research Institute, Cancer Epigenetics, Badalona, Spain
- David Piñeyro
- 1 Josep Carreras Leukaemia Research Institute, Cancer Epigenetics, Badalona, Spain
- Aina Oliver-Caldes
- 3 Hospital Clínic de Barcelona, Universitat de Barcelona, Hematology department, Barcelona, Spain
- Almudena García-Ortiz
- 4 University Hospital October 12, Hematology department, Madrid, Spain
- Antonio Valeri
- 4 University Hospital October 12, Hematology department, Madrid, Spain
- Carlos Fernández De Larrea
- 3 Hospital Clínic de Barcelona, Universitat de Barcelona, Hematology department, Barcelona, Spain
- Joaquin Martínez-López
- 4 University Hospital October 12, Hematology department, Madrid, Spain
- Gerardo Ferrer
- 1 Josep Carreras Leukaemia Research Institute, Cancer Epigenetics, Badalona, Spain
- Manel Esteller
- 1 Josep Carreras Leukaemia Research Institute, Cancer Epigenetics, Badalona, Spain
- DOI
- https://doi.org/10.1097/01.HS9.0000970192.40461.5e
- Journal volume & issue
-
Vol. 7
p. e404615e
Abstract
No abstracts available.